2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, SEPTEMBER 4, 2024 |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY
SINCE 2020 |
THE
"FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP"
(FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY " DISCUSSION WILL INCLUDED:
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
LEGISLATIVE AGENDA FOR 2024 -2025
REF'S ISSUES AND SOLUTIONS
CLICK HERE TO REGISTER FOR THE SEPT 11, 2024 MEETING |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY
CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks). E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast. The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF
MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
Trulieve to Open Florida Medical Cannabis Dispensaries in Cocoa, Miramar Beach, Niceville, and Tampa
Grand opening celebrations at all four locations Friday, September 6th
TALLAHASSEE, Fla., Aug. 30, 2024 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., announced the opening of new medical cannabis dispensaries in Miramar Beach, Niceville, and Tampa today and Cocoa on Saturday.
Grand opening celebrations will be held at all four locations Friday, September 6, beginning at 9 a.m., featuring music, specials, discounts, and opportunities to register for upcoming patient education sessions as well as learn about #YesOn3 and the ballot initiative to legalize adult cannabis use in Florida.
“We are excited to open these new dispensaries, expanding access to medical cannabis in the panhandle, Space Coast and Tampa Bay regions,” said Trulieve’s Chief Executive Officer Kim Rivers. “We look forward to building more relationships with patients and caregivers in Brevard, Hillsborough, Okaloosa, and Walton Counties.”
READ MORE |
Trulieve Employee Training Program Earns Gold Award for Excellence
Trulieve’s TruU-GROW employee training program awarded for Best Competencies and Skill Development
TALLAHASSEE, Fla., Aug. 29, 2024 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced its TruU-GROW cultivation training program has received a Gold award of excellence in the 2024 Brandon Hall Group HCM Excellence Awards™.
“We are proud to see our TruU-GROW program continue to be recognized for its excellence in learning and development,” said Trulieve’s Chief Production Officer Kyle Landrum. “This award is a testament to Trulieve’s commitment to quality by empowering our teams to cultivate their highest potential through training and education.”
The TruU-GROW program received a Gold award for Best Competencies and Skill Development, a new category in 2024, after earning six Brandon Hall Group Gold awards for excellence in 2023.
READ MORE |
Curaleaf Launches Innovative JAMS Remix Fast-Acting Ratio Jellies
Flavorful ratio gummies formulated with cannabinoids and nutraceuticals set to launch across the country
STAMFORD, Conn., Aug. 30, 2024 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced the launch of JAMS Remix, a new line of flavor-forward jellies. JAMS Remix pairs fast-acting onset technology with unique multi-cannabinoid ratios and functional ingredients to deliver cannabis benefits from daytime to nighttime, with Shineapple for morning, Sootheberry for mid-day and Lullaberry for night.
JAMS Remix will initially be available in Arizona on August 30 and New York and Massachusetts (launching with Lullaberry) in late September, with additional markets to follow, pending regulatory approval, including Connecticut, Maryland, New Jersey, Illinois, and Utah.
READ MORE |
Red White & Bloom Reports Second Quarter 2024 Financial Results
TORONTO, Aug. 29, 2024 — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) is pleased to report it has filed its Condensed Interim Consolidated Financial Statements (“the Financial Statements”), Management’s Discussion and Analysis (“MD&A”), and associated certifications for its second quarter ended June 30, 2024.
President’s Commentary
Colby De Zen, President, stated, “In the second quarter, we made notable strides on several strategic initiatives. We advanced refinancing agreements with our strategic lenders, moved closer to opening five new retail locations in Florida in anticipation of stronger legalization prospects, established key distribution partnerships in California to boost market penetration, and strengthened our vendor relationships. Additionally, we worked to mitigate supply chain risks in Michigan by securing value-added crop commitments for quality biomass.”
“These initiatives and investments are expected to drive incremental EBITDA growth in the second half of fiscal 2024. This follows a substantial increase in EBITDA to $7.1 million in the first six months of 2024, representing a year-over-year improvement of over $8 million. Our EBITDA gains for 2024 do not yet include the potential synergies and improvements from the Emblem group of companies, which we expect to impact our results in the latter half of the year.”
READ MORE |
Mint Cannabis and Shango Joint Venture Enters Into Definitives for the Acquisition of the Cannabist Company’s Florida Entity
SEPTEMBER 3, 2024 – TEMPE, Ariz.–(BUSINESS WIRE)–Leading private multi-state operators MINT Cannabis (“MINT”) and Shango (“SHANGO”) announced today that they have, through a joint venture (the “MINT SHANGO JV”), entered into a definitive agreement to acquire all membership interests in The Cannabist Company Holdings Inc.’s (“The Cannabist Company”) (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) Florida subsidiary. This acquisition of a dominant operational Florida vertical is anticipated to provide immediate scale for the MINT SHANGO JV in this state through 14 dispensary locations, two cultivation and manufacturing facilities, all inventory, and its MMTC license (the “MINT/SHANGO Transaction”) for total consideration of $5M. As part of the MINT/SHANGO Transaction, the MINT/SHANGO JV will retain its existing indoor cultivation facility, and The Cannabist Company has separately divested its Lakeland facility. Additionally, the MINT SHANGO JV has also entered into an agreement to transfer to The Cannabist Company all of the outstanding equity interests in its existing MMTC license holder which they plan to divest upon close.
MINT and SHANGO are looking forward to launching their inaugural joint venture in the highly populated state of Florida, expanding their respective multi-state footprints. The MINT SHANGO JV expects to deploy the collective strengths of each operator to provide a leading consumer experience. MINT intends to focus its retail prowess on driving operational excellence in the 14 Cannabist dispensaries, while furthering its organic expansion efforts by securing prime real estate locations in underserved cities across Florida. MINT brings best-in-class retail expertise from its Arizona headquarters to the Florida market. Post-closing, the Cannabist dispensaries are anticipated to be rebranded and operated under the banner “MINT Dispensary.” During the next 18 months, the MINT SHANGO JV has plans to scale its Florida operations to 35 MINT-branded dispensaries.
READ MORE |
DEA Throws a Curveball, Pushing Back Rescheduling Hearing Until After the Election: Viridian Insights of the Week
August 28, 2024- The DEA has scheduled a hearing for December 2 to consider differing expert opinions regarding rescheduling of cannabis to schedule 3. The DEA said that there were a number of requests for the hearing from both supporters and opponents or for rescheduling.
The cannabis equity market lurched violently downward on the news as it clearly pushed the issuance of final rule-making to after the election and probably into Spring 2025. The MSOS ETF closed down 13.35% to $6.10 on Tuesday, August 27.
The panic is overblown. We were never convinced of the rapid deployment of S3 and have always believed that the old Shakespearian line “Many a slip twixt the cup and the lip” applied in triplicate to anything occurring in Washington, D.C., especially as it relates to cannabis. The reaction stems from fear that if Trump wins the election, he may not choose to continue down the rescheduling track. These fears are not based on logic. Trump has proven to be an advocate of states’ rights, and cannabis is the ultimate states’ rights issue. We admit we are a bit perplexed about why he hasn’t seized the issue to his benefit. One would think it would be relatively easy to campaign against the inability of the Democratic party to make any progress on cannabis legislation or regulation in the time they have been in control.
Perhaps a more rational fear is that if the S3 ruling doesn’t happen until 2025, which now seems likely, will companies no longer be able to recoup 280e taxes for 2024? In September 2023, we estimated that the top ten companies would save around $700M annually from S3. Those companies now have an aggregate market cap of about $11.0B. On that basis, a one-year delay in S3 implementation should be worth around 6% of the market cap.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
Cannabis and hallucinogen use among adults remained at historic highs in 2023
Vaping among younger adults and binge drinking among mid-life adults also maintained historically high levels, NIH-supported study shows.
AUGUST 29, 2024 – Past-year use of cannabis and hallucinogens stayed at historically high levels in 2023 among adults aged 19 to 30 and 35 to 50, according to the latest findings(link is external) from the Monitoring the Future survey(link is external). In contrast, past-year use of cigarettes remained at historically low levels in both adult groups. Past-month and daily alcohol use continued a decade-long decline among those 19 to 30 years old, with binge drinking reaching all-time lows. However, among 35- to 50-year-olds, the prevalence of binge drinking in 2023 increased from five and 10 years ago. The Monitoring the Future study is conducted by scientists at the University of Michigan’s Institute for Social Research, Ann Arbor, and is funded by the National Institutes of Health.
Reports of vaping nicotine or vaping cannabis in the past year among adults 19 to 30 rose over five years, and both trends remained at record highs in 2023. Among adults 35 to 50, the prevalences of nicotine vaping and of cannabis vaping stayed steady from the year before, with long-term (five and 10 year) trends not yet observable in this age group as this question was added to the survey for this age group in 2019.
For the first time in 2023, 19- to 30-year-old female respondents reported a higher prevalence of past-year cannabis use than male respondents in the same age group, reflecting a reversal of the gap between sexes. Conversely, male respondents 35 to 50 years old maintained a higher prevalence of past-year cannabis use than female respondents of the same age group, consistent with what’s been observed for the past decade.
READ MORE |
Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company Sep 3, 2024
NEW YORK, Sept. 03, 2024 — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has successfully completed the previously announced acquisition of craft breweries Hop Valley Brewing Company, Terrapin Beer Co., and Revolver Brewing, from Molson Coors Beverage Company (“Molson Coors”) (NYSE: TAP).
Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, said, “Tilray Brands is crafting a new future for brands in the craft beer industry. We are proud to welcome these exceptional brands and the talented teams behind them to Tilray. With our proven track record of creating brand growth, we are confident in our ability to drive revenue, generate cost synergies, and expand distribution, further strengthening these brands and solidifying Tilray’s position as a leader in the craft beverage industry. This strategic acquisition creates additional growth opportunities for our global beverage business, which reinforces our commitment to enhancing shareholder value. At Tilray Brands, we are constantly pushing the boundaries to bring new and better experiences to our consumers. Our plan is to drive growth and maximize the potential of these brands to their fullest capacity, while maintaining our dedication to delivering high-quality products and meeting the evolving needs of our consumers.”
READ MORE |
KEY Investment Partners Announces Launch of Cannabis Credit Offering, Closes Senior Credit Facility
Private markets investment firm expands financing solutions across private equity and private debt
DENVER, Sept. 03, 2024 — KEY Investment Partners today announced it has established a new cannabis credit offering, providing growth capital to cannabis businesses from a trusted source with in-depth knowledge of the industry. In addition, KEY announced the closing of a senior credit facility with The Dispensary, an Illinois cannabis operator seeking to grow its retail footprint and expand its craft cultivation capabilities.
Co-founded in 2015 by Dan Dolan and his son Kevin, The Dispensary is a medical and adult-use cannabis operator in Illinois. The company currently has one medical/adult-use dispensary located in Fulton, and two solely adult-use dispensaries located in East Dubuque and Champaign. The Dispensary sells cannabis products over all of the core product categories like: flower, pre-rolls, concentrates, vapes, edibles, topicals, and tinctures.
READ MORE | Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial
Trial to study Major Depressive Disorder using Optimi’s GMP natural psilocybin capsules in conjunction with therapy
VANCOUVER, BC – August 28, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-compliant, Health Canada-licensed manufacturer of psychedelics pharmaceuticals specializing in botanical psilocybin and MDMA, is pleased to announce the receipt of a No Objection Letter (NOL) from Health Canada. This authorization permits the use of the Company’s GMP natural psilocybin extract capsules in a Phase 2 clinical trial, conducted in collaboration with ATMA Journey Centers LTD. (“ATMA“).
Advancing Clinical Validation in Canada
The approval to initiate this Phase 2 clinical trial represents a pivotal moment in the clinical development of Optimi’s GMP natural psilocybin extract capsules. Building on its established status as a treatment option for patients with treatment-resistant depression (TRD) in Australia, this trial will provide a rigorous evaluation of the capsules in 200 participants within a controlled clinical environment in Canada. The study is scheduled to commence in the coming months, and is expected to yield valuable insights that will contribute to the broader understanding of psilocybin as a potential therapeutic option within the Canadian healthcare system.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA | QUALIFIED PATIENTS
OVER 885,000
AND 673 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
AUGUST 30, 2024 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) AUG 30 2024- 885,373 AUG 23 2024- 885,409
AUG 16 2024- 885,040
AUG 09 2024- 884,982
AUG 02 2024- 884,941
JUL 26 2024- 885,196
Pattients Last Week: -36
Qualified Ordering Physicians: 2,355
New Doctors Last Week: 11 Reporting Period: AUGUST 23 TO AUGUST 29, 2024
Amount of Medical Marijuana Dispensed - (mgs THC) 337,781,400
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,183,146
Amount of Marijuana in a From for Smoking (oz) 119,220.973
Approved Dispensing Locations: 673
Added Last Week: 8 GIT FLORIDA - TALLAHASSEE
JUNGLE BOYS - TALLAHASSEE MUV- OKEECHOBEE & MELBOURNE
TRULIEVE - NICEVILLE, MIRAMAR BEACH, COCOA & TAMPA |
UPCOMING MEETING AND CONFERENCES |
Don’t miss this important one-day event! September 25th – FSU Turnbull Center – Tallahassee
The most comprehensive information related to Florida’s changing marijuana marketplace. Florida could soon be the biggest marijuana market in the country! Register now to meet the people and hear the voices that will shape the future of Florida’s marijuana industry. For more information visit our website or contact MMBAFL@tmcshows.com. (850) 385-3595.
READ MORE |
CANNABIS NEWS FLORIDA READERS CAN RECEIVE A 20% REGISTRATION DISCOUNT BY USING THIS CODE WHEN YOU REGISTER CNF20 |
2024 Florida Cannabis Festival November 2nd and 3rd |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|